Gene editing and AAV6 vectors can trigger inflammatory, senescence-like responses in blood stem cells
Gene Editing’s Next Frontier: Overcoming Hidden Challenges in Blood Disorder Therapies The field of gene therapy is rapidly evolving, offering hope for treating inherited blood disorders. Recent research from the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) in Milan has uncovered a significant hurdle: the unintended consequences of CRISPR-Cas9 gene editing on blood stem … Read more